SEC Comment Letter 0000000000-24-013610 to Radiopharm Theranostics Ltd (RADX, RDPTF) (CIK 0001949257) (RADX)
Radiopharm Theranostics Ltd (RADX, RDPTF) (CIK 0001949257)
Date: Dec. 10, 2024 · CIK: 0001949257 · Accession: 0000000000-24-013610
AI Filing Summary & Sentiment
File numbers found in text: 333-283627
Letter
December 10, 2024 Riccardo Canevari Chief Executive Officer Radiopharm Theranostics Limited Level 3, 62 Lygon Street Carlton, VIC 3053 Australia Re:Radiopharm Theranostics Limited Registration Statement on Form F-1 Filed December 5, 2024 File No. 333-283627 Dear Riccardo Canevari: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Andrew Reilly, Esq.
Show Raw Text
December 10, 2024
Riccardo Canevari
Chief Executive Officer
Radiopharm Theranostics Limited
Level 3, 62 Lygon Street
Carlton, VIC 3053
Australia
Re:Radiopharm Theranostics Limited
Registration Statement on Form F-1
Filed December 5, 2024
File No. 333-283627
Dear Riccardo Canevari:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Andrew Reilly, Esq.